Allurion Technologies this week said it appointed three new executives. Whitney Cypes was appointed VP of global marketing. Cypes has more than 15 years of global marketing of medical devices experience. Prior to joining Allurion, Cypes was the senior director of marketing at Insulet. She has also held a number of leadership roles at Hologic, […]
Allurion Technologies announced today that it raised $34 million in new funding through a securities financing and a growth capital term loan. Natick, Mass.-based Allurion plans to put the proceeds from the funding toward international growth and the launch of its weight loss program in the U.S. once FDA approval is secured, according to a […]
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
Allurion Technologies said today it launched the pivotal Enlighten US clinical trial of its Elipse gastric balloon designed for weight loss. The Elipse gastric balloon is made of a thin, flexible polymer film and is ingested as a capsule without the need for surgery. The balloon is filled once it reaches a patient’s stomach to reduce […]
Cerner Corp. (NSDQ:CERN) said yesterday that it named Brent Shafer to serve as chairman & CEO effective Feb. 1. Shafer previously served as CEO of Philips‘ (NYSE:PHG) North America business. Cerner’s co-founder Cliff Illig has been serving as interim CEO and chairman of the board since July last year. Illig said he plans to resume […]
Allurion Technologies said today it raised $27 million in a Series C round of funding to support its Elipse gastric balloon designed for weight loss. Allurion’s Elipse gastric balloon is made of a thin, flexible polymer film and is ingested as a capsule without the need for surgery. The balloon is filled once it reaches a […]
Natick firm Allurion Technologies raised $19 million of a $27.3 million offering from 45 investors, according to a regulatory filing. The offering made its 1st sale on Jan. 17. The filing did not identify any of the offering’s investors, but disclosed that the financing included $1.1 million from three non-U.S. investors. Allurion makes the ingestible […]
Allurion Technologies said yesterday it won CE Mark approval in the European Union for its Elipse gastric balloon used for weight loss. The Elipse gastric balloon is made of thin, flexible polymer film and is ingested as a swallowable capsule, making its installation non-surgical. The balloon remains in the stomach for 4 months after which […]
Weight-loss devices startup Allurion Technologies closed a $1.7 million funding round, according to the company’s 1st reported filing with the SEC.
The Wellesley, Mass.-based company is working on a balloon, compressed into a swallowable pill, that expands in the stomach.
The balloon remains in the stomach, creating feelings of fullness, until the patient swallows an non-toxic agent that dissolves the balloon. .